Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
LifeStance Health GroupLFST +2.48%56 Intrinsic Value: Projected FCF is $2.97 as of Jul. 18, 2026, which is 30% above its 10-year median of 2.29. GuruFocus rates LFST with a GF Score™ of 56/100 and a GF Value™ of $8.30 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 342 Healthcare Providers & Services companies, LifeStance Health Group ranks worse than 86.55% on this metric.
Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.
The historical rank and industry rank for LifeStance Health Group's Intrinsic Value: Projected FCF or its related term are showing as below:
LFST'
s Price-to-Projected-FCF Range Over the Past 10 Years
Min: 2.14 Med: 2.29 Max: 3.9
Current: 3.9
During the past 7 years, the highest Price-to-Intrinsic-Value-Projected-FCF of LifeStance Health Group was 3.90. The lowest was 2.14. And the median was 2.29.
LFST's Price-to-Projected-FCF is ranked worse than 86.55% of 342
companies
in the Healthcare Providers & Services industry
Industry Median: 1.075
vs LFST: 3.90
LifeStance Health Group (NAS:LFST) Intrinsic Value: Projected FCF Explanation
The growth multiple is capped between 8.35 and 17.74.
Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.
LifeStance Health Group's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as
Price-to-Intrinsic-Value-Projected-FCF
=
Share Price
/
Intrinsic Value: Projected FCF
=
11.58
/
2.9653677929242
=
3.91
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LifeStance Health Group Intrinsic Value: Projected FCF Related Terms
LifeStance Health Group Intrinsic Value: Projected FCF Historical Data
* Premium members only.
The historical data trend for LifeStance Health Group's Intrinsic Value: Projected FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LifeStance Health Group Intrinsic Value: Projected FCF Chart
LFST vs CON, BKD, OPCH: Intrinsic Value: Projected FCF Comparison
For the Medical Care Facilities subindustry, LifeStance Health Group's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LifeStance Health Group Price-to-Projected-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, LifeStance Health Group's Price-to-Projected-FCF distribution charts can be found below:
* The bar in red indicates where LifeStance Health Group's Price-to-Projected-FCF falls into.
LifeStance Health Group Intrinsic Value: Projected FCF Calculation
Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.
The details of how we calculate the intrinsic value of stocks are described in detail here.
This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Intrinsic Value: Projected FCF of $2.97 mean?
LifeStance Health Group (LFST) has a Intrinsic Value: Projected FCF of $2.97 as of Jul. 18, 2026. Intrinsic Value: Projected FCF is the stock value based on a projected free cash flow model. View historical data on LifeStance Health Group and its competitors. This is 30% above median its historical median of 2.29. Over the past decade, LifeStance Health Group's Intrinsic Value: Projected FCF has ranged from 2.14 to 3.90. According to the industry distribution chart, LifeStance Health Group ranks #296 out of 342 companies in the Healthcare Providers & Services industry, placing it in the top 86.5%.
Is LifeStance Health Group's Intrinsic Value: Projected FCF too high?
LifeStance Health Group's current Intrinsic Value: Projected FCF of $2.97 is 30% above median its 10-year median of 2.29. Over the past 10 years, this metric has ranged from a low of 2.14 to a high of 3.90. The Healthcare Providers & Services industry median Intrinsic Value: Projected FCF is 1.08. LifeStance Health Group's value of $2.97 is 176.3% above this industry median. Based on the distribution chart, LifeStance Health Group ranks #296 out of 342 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, LifeStance Health Group has a GF Score™ of 56/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does LifeStance Health Group's Intrinsic Value: Projected FCF compare to CON and BKD?
According to the Healthcare Providers & Services industry distribution chart, LifeStance Health Group ranks #296 out of 342 companies for Intrinsic Value: Projected FCF. This places LifeStance Health Group in the lower half of its industry. The industry median Intrinsic Value: Projected FCF is 1.08. LifeStance Health Group's value of $2.97 is 176.3% above this benchmark. Historically, LifeStance Health Group's own Intrinsic Value: Projected FCF has ranged from 2.14 to 3.90 over the past decade. While the company's 10-year median is 2.29 vs. the industry median of 1.08, LifeStance Health Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Intrinsic Value: Projected FCF for a Healthcare Providers & Services company?
The median Intrinsic Value: Projected FCF among Healthcare Providers & Services companies is 1.08, based on 342 companies in the industry. Companies in the top quartile (top 25%) have a Intrinsic Value: Projected FCF significantly above this median, while those in the bottom quartile fall well below. However, Intrinsic Value: Projected FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. LifeStance Health Group's current Intrinsic Value: Projected FCF of $2.97 is 176.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Intrinsic Value: Projected FCF mean?
A high Intrinsic Value: Projected FCF can signal that a stock is expensive relative to its fundamentals. Intrinsic Value: Projected FCF is the stock value based on a projected free cash flow model. View historical data on LifeStance Health Group and its competitors. For the Healthcare Providers & Services industry, the median Intrinsic Value: Projected FCF is 1.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LifeStance Health Group's current Intrinsic Value: Projected FCF is $2.97, which is 30% above median its own 10-year median of 2.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LifeStance Health Group stock overvalued right now?
Based on GuruFocus' analysis, LifeStance Health Group (LFST) is currently considered Significantly Overvalued. The stock's GF Value™ is $8.30, compared to a current price of $11.58 — trading 39.5% above its estimated fair value. The current Intrinsic Value: Projected FCF is $2.97, which is 30% above median its 10-year median of 2.29 and 176.3% above the Healthcare Providers & Services industry median of 1.08. LifeStance Health Group's overall GF Score™ is 56/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Intrinsic Value: Projected FCF calculated?
Intrinsic Value: Projected FCF is calculated from a company's financial statements. For LifeStance Health Group (LFST), the current Intrinsic Value: Projected FCF is $2.97 as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is LifeStance Health Group (LFST) Overvalued in 2026?
Based on GuruFocus' analysis, LifeStance Health Group stock appears to be overvalued.
The current stock price of $11.58 is trading 39.5% above its estimated GF Value™ of $8.30.
GuruFocus considers LifeStance Health Group to be Significantly Overvalued.
Key valuation signals for LFST:
Intrinsic Value: Projected FCF: $2.97 (30% above median its 10-year median of 2.29)
GF Value™: $8.30 vs. price of $11.58 (39.5% above fair value)
Industry Position: 176.3% above the Healthcare Providers & Services median (#296 of 342)
No single metric tells the full story. See the LFST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family, and group therapy. It treats a broad range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder, using evidence-based approaches to ensure effective treatment. The group has a single operating and reportable segment of mental health services.
56GF Score
Get the complete analysis for LFST
Intrinsic Value: Projected FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LFST has been successfully added to your 
